Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ABBV | MRK | AZN | ||
Company | Abbvie Inc | Merck & Company | Astrazeneca Plc ADR | ||
Price Information | |||||
Exchange | NYSE | NYSE | NASDAQ | ||
Open | 167.09 | 130.13 | 75.00 | ||
High | 167.46 | 131.91 | 75.49 | ||
Low | 157.65 | 130.13 | 74.59 | ||
Last | 159.62 | 131.20 | 75.17 | ||
Change | -7.67 | +0.48 | +0.14 | ||
% Change | -4.58% | +0.37% | +0.19% | ||
Volume | 10,721,700 | 7,758,200 | 6,687,900 | ||
20-Day Average Volume | 5,540,975 | 6,900,380 | 6,053,005 | ||
Previous Close | 167.29 | 130.72 | 75.03 | ||
Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 168.36 | 127.46 | 69.16 | ||
20-Day Raw Stochastic | 8.12% | 80.72% | 93.21% | ||
20-Day Relative Strength | 34.99% | 65.14% | 76.11% | ||
Weighted Alpha | +5.84 | +20.42 | +9.65 | ||
Today's Opinion | 8% Buy | 100% Buy | 88% Buy | ||
Previous Opinion | 24% Buy | 100% Buy | 88% Buy | ||
Last Month's Opinion | 96% Buy | 80% Buy | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -4.08% since 04/19/24 | +4.31% since 04/19/24 | +9.66% since 04/19/24 | ||
Low | 157.65 on 04/26/24 | 125.35 on 04/24/24 | 69.38 on 04/22/24 | ||
High | 170.37 on 04/23/24 | 132.80 on 04/25/24 | 75.81 on 04/25/24 | ||
1-Month | |||||
%Chg | -10.92% since 03/26/24 | +4.53% since 03/26/24 | +13.33% since 03/26/24 | ||
Low | 157.65 on 04/26/24 | 124.50 on 04/18/24 | 66.39 on 04/03/24 | ||
High | 182.30 on 03/28/24 | 133.10 on 03/27/24 | 75.81 on 04/25/24 | ||
3-Month | |||||
%Chg | -2.91% since 01/26/24 | +8.59% since 01/26/24 | +12.03% since 01/26/24 | ||
Low | 157.65 on 04/26/24 | 119.23 on 03/15/24 | 60.47 on 02/12/24 | ||
High | 182.89 on 03/12/24 | 133.10 on 03/27/24 | 75.81 on 04/25/24 | ||
6-Month | |||||
%Chg | +9.93% since 10/26/23 | +24.30% since 10/26/23 | +18.55% since 10/26/23 | ||
Low | 135.85 on 11/09/23 | 99.80 on 11/29/23 | 60.47 on 02/12/24 | ||
High | 182.89 on 03/12/24 | 133.10 on 03/27/24 | 75.81 on 04/25/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 282,630,656 | 332,333,280 | 233,060,304 | ||
Shares Outstanding, K | 1,770,647 | 2,533,028 | 3,100,443 | ||
Annual Sales | 54,318,000,000 | 60,115,000,000 | 45,811,000,000 | ||
Annual Net Income | 4,863,000,000 | 365,000,000 | 5,955,000,000 | ||
Last Quarter Sales | 14,301,000,000 | 14,631,000,000 | 12,024,000,000 | ||
Last Quarter Net Income | 822,000,000 | -1,226,000,000 | 960,000,000 | ||
60-Month Beta | 0.58 | 0.38 | 0.50 | ||
Per-Share Information | |||||
Most Recent Earnings | 2.31 on 04/26/24 | 2.07 on 04/25/24 | 2.06 on 04/25/24 | ||
Latest Earnings Date | 04/26/24 | 04/25/24 | 04/25/24 | ||
Most Recent Dividend | 1.550 on 04/12/24 | 0.770 on 03/14/24 | 0.965 on 02/22/24 | ||
Next Ex-Dividends Date | 04/12/24 | 03/14/24 | 02/22/24 | ||
Ratios | |||||
Price/Earnings ttm | 15.06 | 60.24 | 20.22 |